On August 23, 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine.
The much-anticipated approval was given to the Pfizer-BioNTech COVID-19 Vaccine, which is for those ages 16 and older. The vaccine will be marketed as Comirnaty, according to an FDA news release.
Prior to August 23, the vaccine was distributed to citizens under the Emergency Use Authorization (EUA). This authorization allows the FDA to strengthen the nation’s public health protections that include infectious diseases by getting medical countermeasures out during public health emergencies.

